爱泼斯坦-巴尔病毒
病毒进入
生物
疱疹病毒糖蛋白B
病毒
脂质双层融合
细胞生物学
人类白细胞抗原
受体
病毒学
病毒蛋白
遗传学
病毒复制
抗原
作者
Britta S. Möhl,Jia Chen,Karthik Sathiyamoorthy,Theodore S. Jardetzky,Richard Longnecker
出处
期刊:Molecules and Cells
[Springer Science+Business Media]
日期:2016-04-01
卷期号:39 (4): 286-291
被引量:54
标识
DOI:10.14348/molcells.2016.0066
摘要
Epstein-Barr virus (EBV) is the prototypical γ-herpesvirus and an obligate human pathogen that infects mainly epithelial cells and B cells, which can result in malignancies. EBV infects these target cells by fusing with the viral and cellular lipid bilayer membranes using multiple viral factors and host receptor(s) thus exhibiting a unique complexity in its entry machinery. To enter epithelial cells, EBV requires minimally the conserved core fusion machinery comprised of the glycoproteins gH/gL acting as the receptor-binding complex and gB as the fusogen. EBV can enter B cells using gp42, which binds tightly to gH/gL and interacts with host HLA class II, activating fusion. Previously, we published the individual crystal structures of EBV entry factors, such as gH/gL and gp42, the EBV/host receptor complex, gp42/HLA-DR1, and the fusion protein EBV gB in a postfusion conformation, which allowed us to identify structural determinants and regions critical for receptor-binding and membrane fusion. Recently, we reported different low resolution models of the EBV B cell entry triggering complex (gHgL/gp42/HLA class II) in "open" and "closed" states based on negative-stain single particle electron microscopy, which provide further mechanistic insights. This review summarizes the current knowledge of these key players in EBV entry and how their structures impact receptor-binding and the triggering of gB-mediated fusion.
科研通智能强力驱动
Strongly Powered by AbleSci AI